Literature DB >> 22466334

PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.

Rachel Reynaud1, Sujatha A Jayakody, Carine Monnier, Alexandru Saveanu, Jérome Bouligand, Anne-Marie Guedj, Gilbert Simonin, Pierre Lecomte, Anne Barlier, Philippe Rondard, Juan Pedro Martinez-Barbera, Anne Guiochon-Mantel, Thierry Brue.   

Abstract

CONTEXT: Pituitary stalk interruption represents a frequent feature of congenital hypopituitarism, but only rare cases have been assigned to a known genetic cause.
OBJECTIVE: Using a candidate gene approach, we tested several genes as potential causes of hypopituitarism with pituitary stalk interruption. We hypothesized that ectopic posterior pituitary may be a consequence of defective neuronal axon projections along the pituitary stalk or defective angiogenesis of hypophyseal portal circulation. Considering the role of the prokineticin 2 pathway in angiogenesis and neuronal migration, we screened PROK2 and PROKR2 genes.
DESIGN: PROK2 and PROKR2 and all genes previously known to be involved in hypopituitarism with pituitary stalk interruption (LHX4, HESX1, OTX2, and SOX3) were screened in 72 index cases with pituitary stalk interruption syndrome from the GENHYPOPIT database. In vitro studies were performed to assess the functional consequences of allelic variants.
RESULTS: We identified two heterozygous PROKR2 mutations (p.Leu173Arg and p.Arg85His) previously reported in isolated hypogonadotroph hypogonadism and a novel PROKR2 variant (p.Ala51Thr) that, in contrast with both other mutations, did not impair receptor signaling activity. Three allelic variants of HESX1 were identified: the heterozygous p.Phe156Ser and the homozygous p.Arg109X mutations were functionally deleterious, whereas p.Ser67Thr was found as a rare allelic variant in association with p.Arg85His PROKR2 mutation in the same patient.
CONCLUSIONS: We report PROKR2 variants in congenital hypopituitarism with pituitary stalk interruption, suggesting a potential role of the prokineticin pathway in pituitary development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466334     DOI: 10.1210/jc.2011-3056

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model.

Authors:  Zaid Mohsen; Hosung Sim; David Garcia-Galiano; Xingfa Han; Nicole Bellefontaine; Thomas L Saunders; Carol F Elias
Journal:  Brain Struct Funct       Date:  2017-06-14       Impact factor: 3.270

2.  Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.

Authors:  Junjie Zheng; Jiangfeng Mao; Hongli Xu; Xi Wang; Bingkun Huang; Zhaoxiang Liu; Mingxuan Cui; Shuyu Xiong; Wanlu Ma; Le Min; Ursula B Kaiser; Min Nie; Xueyan Wu
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

3.  Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome.

Authors:  Ravikumar Balasubramanian; Sheena Chew; Sarah E MacKinnon; Peter B Kang; Caroline Andrews; Wai-Man Chan; Elizabeth C Engle
Journal:  J Clin Endocrinol Metab       Date:  2015-01-05       Impact factor: 5.958

4.  Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome.

Authors:  Ender Karaca; Ramazan Buyukkaya; Davut Pehlivan; Wu-Lin Charng; Kursat O Yaykasli; Yavuz Bayram; Tomasz Gambin; Marjorie Withers; Mehmed M Atik; Ilknur Arslanoglu; Semih Bolu; Serkan Erdin; Ayla Buyukkaya; Emine Yaykasli; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

Review 5.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

6.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

Review 7.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

8.  PROK2/PROKR2 Signaling and Kallmann Syndrome.

Authors:  Catherine Dodé; Philippe Rondard
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-12       Impact factor: 5.555

9.  Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.

Authors:  Mark J McCabe; Carles Gaston-Massuet; Louise C Gregory; Kyriaki S Alatzoglou; Vaitsa Tziaferi; Oualid Sbai; Philippe Rondard; Koh-hei Masumoto; Mamoru Nagano; Yasufumi Shigeyoshi; Marija Pfeifer; Tony Hulse; Charles R Buchanan; Nelly Pitteloud; Juan-Pedro Martinez-Barbera; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

10.  Pituitary stalk interruption syndrome in 53 postpubertal patients: factors influencing the heterogeneity of its presentation.

Authors:  Luu-Ly Pham; Pierre Lemaire; Annie Harroche; Jean-Claude Souberbielle; Raja Brauner
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.